With a rapidly aging boomer population, this is a good time to be looking at a company like ArthroCare (NASDAQ: ARTC), which manufactures products that enable minimally invasive surgery. Its sports medicine division offers products to surgeons working on knees, ankles, elbows, hips, and other joints that are taking steady pounding among the millions of boomers who continue to lead active lifestyles. In addition to sports medicine, ARTC also has divisions focusing on products for the spine; ears, nose, and throat; and other general areas such as gynecology, cardiology, and urology.

All of these areas will be in increasing demand as the boomers age, and I think this is a company with enormous growth potential. Its revenues have been increasingly steadily over the past couple years, and the first quarter of 2007 showed an 18% growth over the first quarter of 2006. ARTC is scheduled to release its second-quarter earnings on Thursday, and BMO Financial Group recently released a report predicting revenue growth of 19% and EPS growth of 27% over the second quarter of 2006. BMO also forecast a jump in the stock price, all the way up to $53 (it's currently at $47), and I think they're absolutely right.